Multidrug-resistant tuberculosis: case reports study in a central state of Brazil

Araújo-Filho, João Alves de; Vasconcelos-Júnior, Arioldo Carvalho; Sousa, Eduardo Martins de; Silveira, Colombina da; Sousa, Patrícia Tavares Pereira de; Severo, Klaus Andrade; Vieira, Ludmila Ferreira; Kipnis, André; Junqueira-Kipnis, Ana Paula.
Braz. j. infect. dis ; 12(1): 94-98, Feb. 2008. ilus, tab
Artigo em Inglês | LILACS | ID: lil-484427

Documentos relacionados

  1. Rifampicin drug resistance and host immunity in tuberculosis: more than meets the eye.
  2. Micro-nanoemulsion and nanoparticle-assisted drug delivery against drug-resistant tuberculosis: recent developments.
  3. Effectiveness of Bedaquiline Use beyond Six Months in Patients with Multidrug-Resistant Tuberculosis.
  4. Clinical research progress of novel antituberculosis drugs on multidrug-resistant tuberculosis.
  5. Mathematical models of drug-resistant tuberculosis lack bacterial heterogeneity: A systematic review.
  6. Interventions to Improve Adherence to Medication on Multidrug-Resistant Tuberculosis Patients: A Scoping Review.
  7. [Annual progress of immunotherapy for tuberculosis in 2023].
  8. Costs and import costs of past, present, and future TB drug regimens: a case study for Karakalpakstan, Uzbekistan.
  9. Cost of digital technologies and family-observed DOT for a shorter MDR-TB regimen: a modelling study in Ethiopia, India and Uganda.
  10. Prothionamide Dose Optimization Using Population Pharmacokinetics for Multidrug-Resistant Tuberculosis Patients.